Yggdrasil Gaming Move into Latin American Market
Just a few short days after launching the Sahara Nights video slot, the innovative iGaming developer, Yggdrasil Gaming, signed a deal that saw it move into Latin America, one of the biggest and fastest growing regions in the gambling sector.
The Malta-headquartered brand used an official press release to announce the agreement and to state that it would see its portfolio of mobile-friendly titles become available for Latin players. These titles will be added to the Patagonia Entertainment game aggregation platform, after which they will be offered to players throughout the region.
The Yggdrasil Gaming brand is owned by Cherry AB, an online casino giant that is also responsible for Betsson. The new deal means that Yggdrasil Gaming’s slots, over 60 of them in total, will be provided to a plethora of iGaming operators. Its titles include The One-Armed Bandit, Jackpot Raiders, Wild Robo Factory and Yokozuna Clash, among others.
It also has a range of gamification tools that make it easier for casinos to market the games, getting more eyes on them and generating more plays.
A spokesperson for Yggdrasil Gaming called the deal a “landmark partnership” and also noted that it would include their most successful titles, including the Vikings series. This means that Viking Go to Hell, Vikings Go Wild, and Vikings Go to Bezerk will all be offered to players in this newly regulated market.
“Our aim is to deliver the best casino games,” the spokesperson went on to say, focusing on the potential of this market and describing how positive it would be for the company.
A Strong Foothold
A spokesperson from Patagonia Entertainment also commented on this deal. The firm, which was established back in 2014, maintains a strong position within the Latin American market, particularly in Colombia and Mexico, and sees this deal as hugely beneficial going forward.
“We can’t wait to get started,” they said, before commenting on the many exciting opportunities that Yggdrasil Gaming will bring them.